ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in April 2025. Updated April 14, 2025.
A roundup of FDA’s actions in April 2025.
FDA Output, April 2025
×
